Thursday, February 12, 2015
08:00 – 08:45 Gathering, Refreshments and Exhibition Visit
08:45 – 09:00 Opening Ceremony
Zaza Iakobishvili, Rabin Medical Center
Eyran Halpern, Rabin Medical Center
09:00 – 10:40 Session 1: Cardio-oncology partnership
Chairs: Zaza Iakobishvili, Pia Raanani, Avishay Sella
09:00 – 09:20 Scope of the Field of Cardio- Oncology
Giuseppe CuriglianoEuropean Institute of Oncology, Italy
09:20 – 09:25 Q & A
09:25 – 09:40 A Cardio-Oncology Clinic in Israel – The RMC experience
Zaza Iakobishvili, Rabin Medical Center
09:40 – 09:45 Q & A
09:45 – 09:55 In the Bottom of the Heart  – Case presentation
Amos Levi, Rabin Medical Center
09:55 – 10:10 The Role of Cardiac MRI in the Evaluation of Patients with Suspected Intra-Cardiac Masses
Eli Konen, Sheba Medical Center
10:10 -10:20 Q & A
10:20 – 10:35 Early Diagnosis of Cardiotoxicity in Childhood Cancer: The Role of Myocardial Strain
Livia Kapusta, Sourasky Medical Center
10:35 – 10:40 Q & A
10:40 – 11:10 Coffee Break, Refreshments and Exhibition Visit
11:10 – 13:15 Session 2: Chemotherapy and Cardiotoxicity
Chairs: Tuvia Ben Gal, Ariel Aviv, Rinat Yerushalmi
11:10 – 11:25 Telomere Shortening, Chemotherapy and Cardiotoxicity
Meir Lahav, Rabin Medical Center
11:25- 11:30 Q & A
11:30- 11:40 Anthracycline Cardiotoxicity -Case presentation  – Hadas Ofek , Rabin Medical Center
11:40 – 11:55 Prior Chemotherapy and Cardiotoxicity in Breast Cancer
David Geffen, Soroka Medical Center
11:55 – 12:00 Q & A
12:00 – 12:30 Childhood Cancer Cardiotoxicity: Beginning with the End in Mind
Steven Lipshultz, Children’s Hospital of Michigan, Detroit, MI, USA
12:30 – 12:40 Panel Discussion: How to avoid Anthracycline – Induced Cardiotoxicity, Moderator: Rinat Yerushalmi, Rabin Medical Center
12:40 – 12:50 Atrial Fibrillation in a CLL Patient Treated with Ibrutinib
Yishay Wasserstrum, Rabin Medical Center
12:50 – 13:10 Tyrosine Kinase Inhibitors and Cardiovascular Disease
Pia Raanani, Rabin Medical Center
13:10 – 13:15 Q & A
13:15- 14:15 Lunch Break and Exhibition Visit
14:15 – 16:25 Session 3: Cardiotoxicity – Chimera with a Thousand Faces
Chairs: Offer Amir, Moshe Mittleman, Ido Wolf
14:15 – 14:30 Research Opportunities that Overlap Cardiology and Oncology
Giuseppe Curigliano, European Institute of Oncology, Milano, Italy
14:30 – 14:45 Defining Cardiotoxicity: Do we have all the answers?
Zaza Iakobishvili, Rabin Medical Center
14:45 – 15:00 Panel Discussion: How to Define Cardiotoxicity? Moderator: Ran Kornowski, Rabin Medical Center
15:00 – 15:10 Myocardial Infarction in a Young Childhood Hodgkin Lymphoma Survivor – Case Presentation, Uri Landes, Rabin Medical Center
15:10-15:35 Cardiac Complications of Radiotherapy
Joachim Yahalom, Memorial Sloan-Kettering Cancer Center, NY, USA
15:35 – 15:40 Q & A
15:40 – 15:50 MI in a Patient Treated with 5FU -Case Presentation
Michal Sarfati, Rabin Medical Center
15:50-16:10 Fluoropyrimidine Cardiotoxicity
Chiara Lestuzzi, National Cancer Institute CRO, Aviano, PN, Italy
16:10- 16:15 Q & A
16:15 – 16:25 Closing remarks and Take Home Messages (1)
Conference Chairpersons
Friday, February 13, 2015
08:30 – 09:00 Gathering and Refreshments
09:00 – 10:55 Session 4: Defeat the Cancer, Save the Heart
Chairs: Gad Keren, Dina Ben Yehuda, Noa Ben-Baruch 
09:00 – 09:15 Anticancer Drug Induced QT Interval Prolongation – a Regulatory or a Clinical Problem?
Boaz Mendzelevski , BioClinica Inc, London, UK
09:15 – 09:20 Q & A
09:20 – 09:35 Proposal for Israel Heart Society Position Paper on Cancer Treatment Cardiotoxicity
Michael Arad, Sheba Medical Center
09:35 – 09:40 Q & A
09:40 – 10:05 Malignant Pericardial Effusion – Diagnosis and Management
Daliah Tsoref, Rabin Medical Center
10:05 – 10:10 Q & A
10:10 – 10:30 Cardiac Amyloidosis- update
Arthur Pollak, Hadassah Medical Center
10:30 – 10:35 Q & A
10:35- 10:45 AL Cardiac Amyloidosis – case presentation
Eli Muchtar , Rabin Medical Center
10:45 – 10:55 Panel Discussion:Cardiac Amyloidosis: Where are we heading with the disease? Moderator : Zaza Iakobishvili, Rabin Medical Center
10:55 – 11:10 Coffee Break and Refreshments
11:10 – 12:10 Session 5: Heart Failure and Cancer: New Paradigm?
Chairs: Dov freimark, Avigdor Abraham, Baruch Brenner
11:10 – 11:25 Increased Risk of Cancer in Heart Failure
Tal HasinShaare Zedek Medical Center
11:25 – 11:30 Q & A
11:30 – 11:45 The Impact of anticancer agent Cardiotoxicity on Drug Development and Regulatory Approvals
Boaz Mendzelevski, BioClinica Inc, London, UK
11:45 – 11:50 Q & A
11:50 – 12:10 Closing Remarks and Take Home Messages (2)
12:10 -13:10 Adjourn and Lunch
The Program is subject to changes